{"schema_version":"secwatch.filing_event.v1","accession":"0001517022-24-000007","form_type":"8-K","ticker":"AKBA","cik":"0001517022","company_name":"Akebia Therapeutics, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.460145+00:00","generated_at":"2026-06-07T02:14:14.601760+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Akebia Therapeutics appoints Richard Malabre as Chief Accounting Officer","bullets":["Richard C. Malabre named CAO effective January 8, 2024, reporting to CFO Ellen Snow.","Base salary of $380,000; annual cash bonus target up to 35% of base salary.","Granted options for 336,000 shares (4-year vest) and RSUs for 223,950 shares (3-year vest).","Malabre previously CFO of Ultivue, Inc. and VP/Corporate Controller at Oxford Immunotec.","Company will enter into standard Indemnification and Executive Severance Agreements."],"urls":{"canonical":"https://secwatch.observer/filing/0001517022-24-000007","json":"https://secwatch.observer/filing/0001517022-24-000007.json","markdown":"https://secwatch.observer/filing/0001517022-24-000007.md","text":"https://secwatch.observer/filing/0001517022-24-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517022/000151702224000007/0001517022-24-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517022/000151702224000007/akba-20240108.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:14:14.601760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e3ccb05ed0","claim":"Richard C. Malabre was appointed as Chief Accounting Officer at Akebia Therapeutics, Inc..","evidence_excerpt":"On January 8, 2024, Akebia Therapeutics, Inc. (the “Company”) announced the appointment of Richard C. Malabre as Chief Accounting Officer and principal accounting officer, effective January 8, 2024 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1517022/000151702224000007/0001517022-24-000007-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}